Li Xingyu, Li Mingyu, Mao Zichao, Du Yue, Brown Sylvia, Min Xiaoyu, Zhang Ruiqi, Zhong Yun, Dong Yumei, Liu Zhengjie, Lin Chun
College of Science, Yunnan Agricultural University, Kunming 650201, China.
College of Agriculture and Biotechnology, Yunnan Agricultural University, Kunming 650201, China.
Evid Based Complement Alternat Med. 2022 Apr 27;2022:3641586. doi: 10.1155/2022/3641586. eCollection 2022.
, an important traditional folk medicinal plant, elucidating its bioactive compound profiles and their molecular mechanisms of action on human health, would better understand its traditional therapies and guide their use in preclinical and clinical. This study aims to detect the critical therapeutic compounds, predict their targets, and explore potential therapeutic molecular mechanisms. This work first determined metabolites from roots, stems, and flowering twigs of by a widely targeted metabolomic analysis assay. Then, the drug likeness of the compounds and their pharmacokinetic profiles were screened by the ADMETlab server. The target proteins of active compounds were further analyzed by PPI combing with GO and KEGG cluster enrichment analysis. Finally, the interaction networks between essential compounds, targets, and disease-associated pathways were constructed, and the essential compounds binding to their possible target proteins were verified by molecular docking. Five key target proteins (EGFR, HSP90AA1, SRC, TNF, and CASP3) and twelve correlated metabolites, including aknadinine, cephakicine, homostephanoline, and N-methylliriodendronine associated with medical applications of , were identified, and the compounds and protein interactions were verified. The key active ingredients are mainly accumulated in the root, which indicates that the root is the main medicinal tissue. This study demonstrated that might exert the desired disease efficacy mainly through twelve components interacting via five essential target proteins. EGFR is the most critical one, which deserves further verification by biological studies.
作为一种重要的传统民间药用植物,阐明其生物活性化合物谱及其对人类健康的分子作用机制,将有助于更好地理解其传统疗法,并指导其在临床前和临床中的应用。本研究旨在检测关键治疗化合物,预测其靶点,并探索潜在的治疗分子机制。这项工作首先通过广泛靶向代谢组学分析方法确定了[植物名称]根、茎和花枝中的代谢物。然后,通过ADMETlab服务器筛选化合物的类药性及其药代动力学特征。通过蛋白质-蛋白质相互作用(PPI)结合基因本体论(GO)和京都基因与基因组百科全书(KEGG)聚类富集分析进一步分析活性化合物的靶蛋白。最后,构建了关键化合物、靶点和疾病相关途径之间的相互作用网络,并通过分子对接验证了关键化合物与其可能的靶蛋白的结合。鉴定出五个关键靶蛋白(表皮生长因子受体(EGFR)、热休克蛋白90α家族成员1(HSP90AA1)、肉瘤病毒癌基因同源物(SRC)、肿瘤坏死因子(TNF)和半胱天冬酶3(CASP3))和十二种相关代谢物,包括与[植物名称]医学应用相关的阿克那定碱(aknadinine)、头孢卡品碱(cephakicine)、高斯蒂芬诺林(homostephanoline)和N-甲基鹅掌楸碱(N-methylliriodendronine),并验证了化合物与蛋白质的相互作用。关键活性成分主要积累在根部,这表明根是主要的药用组织。本研究表明,[植物名称]可能主要通过十二种成分经由五个关键靶蛋白相互作用发挥预期的疾病疗效。EGFR是最关键的一个,值得通过生物学研究进一步验证。